Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Artificial Cycle for FET in PCOS
NCT04002635Phase 4Withdrawn
- Sponsor
- CRG UZ Brussel
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by CRG UZ Brussel. Primary endpoint: Early pregnancy loss. Planned start Dec 2020; status: withdrawn.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on NCT04002635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002635.